Metabolism

7-Keto-DHEA is a naturally occurring DHEA metabolite studied in humans for its ability to elevate resting metabolic rate (RMR) and support thermogenesis, particularly during caloric restriction. A small number of randomized, double-blind, placebo-controlled trials show modest improvements in RMR, body weight, and body composition at 200 mg/day. However, the overall evidence base is limited by very few qualifying studies, small sample sizes, short durations, and industry sponsorship, leaving clinical consensus uncertain.

Acetyl-L-Carnitine (ALCAR) plays a well-documented role in cellular energy metabolism by facilitating the transport of acetyl groups across the mitochondrial inner membrane, directly feeding the tricarboxylic acid (TCA) cycle and supporting aerobic ATP production. Clinical and mechanistic research confirms it acts as a cofactor in fatty acid β-oxidation and modulates key enzymes in glycolysis and gluconeogenesis. Human and animal studies support its ability to improve insulin-stimulated glucose disposal and mitigate metabolic inflexibility associated with mitochondrial dysfunction.

Ajwain has been shown to stimulate digestive enzyme activity (pancreatic lipase, amylase) and accelerate gastrointestinal transit in animal studies, representing scientifically documented metabolic effects. Antidiabetic preclinical evidence (alpha-glucosidase inhibition) also supports a metabolic role.

A. muciniphila is consistently inversely correlated with obesity and metabolic syndrome in humans, and clinical supplementation in overweight/obese individuals reduced body weight, fat mass, and hip circumference trends alongside significant improvements in insulin sensitivity and cholesterol. Animal model data show the organism modulates energy harvest, lipid oxidation, and adipogenesis. It is characterized as a 'next-generation probiotic' with broad metabolic benefits.

Alpha-Lipoic Acid (ALA) is an endogenous mitochondrial cofactor with well-documented roles in metabolic regulation, including glucose uptake, insulin sensitivity, lipid metabolism, and energy expenditure. Multiple randomized controlled trials and meta-analyses confirm that supplemental ALA improves key metabolic parameters—including fasting glucose, insulin resistance, body weight, BMI, triglycerides, and total cholesterol—particularly in individuals with metabolic syndrome, type 2 diabetes, obesity, and insulin-resistant states. Evidence is graded as scientific, supported by extensive human clinical data.

AMPK is a well-established master regulator of cellular energy and metabolism, activated when the AMP/ATP ratio rises during energy stress. It simultaneously suppresses anabolic (energy-consuming) pathways and activates catabolic (energy-producing) pathways, including glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. Clinical evidence from human skeletal muscle studies and metformin trials confirms that AMPK activation translates into measurable improvements in glucose and lipid metabolism.

Amylase is the primary enzyme responsible for dietary starch catabolism, directly governing carbohydrate metabolism and energy availability. AMY1 gene copy number variation is associated with BMI, obesity risk, and broader metabolic parameters including lipid homeostasis. Low serum amylase is consistently associated with impaired metabolic states.

Apple cider vinegar (ACV) has human clinical evidence supporting modest improvements in key metabolic parameters, including fasting blood glucose, HbA1c, insulin sensitivity, body weight, and BMI. Its primary active compound, acetic acid, appears to act via delayed gastric emptying, inhibition of disaccharidase and alpha-amylase activity, and activation of hepatic AMPK. A 2023 meta-analysis of 25 clinical trials found significant reductions in fasting blood glucose and HbA1c, though effect sizes are moderate and study quality is variable.

Ashitaba chalcones activate AMPK — a master regulator of cellular energy metabolism — in adipose tissue and liver. This drives fat oxidation, reduces lipogenesis, and improves insulin signaling in animal models. Human pilot trials targeting metabolic syndrome markers (visceral fat, blood sugar, lipids) used 200–220 mg/day standardized extract.

Berberine has robust clinical and mechanistic evidence supporting its role in metabolic health, particularly glucose and lipid regulation. Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate significant reductions in fasting blood glucose, triglycerides, LDL-cholesterol, BMI, and waist circumference. Its primary mechanism involves activation of AMP-activated protein kinase (AMPK), a central regulator of cellular energy balance, alongside additional pathways modulating insulin sensitivity and lipid biosynthesis.

Betaine is a core substrate in one-carbon metabolism, donating methyl groups to regenerate SAM — the universal methyl donor for DNA methylation, amino acid synthesis, lipid metabolism, and neurotransmitter production. This metabolic role is well-documented in liver and kidney tissue. Betaine also functions as an osmoprotectant, maintaining cell volume and protein stability under osmotic stress.

Bile acids function as systemic metabolic hormones beyond their digestive role, acting via FXR and TGR5 to regulate energy expenditure, thermogenesis, hepatic glucose production, triglyceride synthesis, and insulin sensitivity. TGR5 activation in brown adipose tissue and skeletal muscle increases energy expenditure via thyroid hormone conversion. Bile acid levels rise after bariatric surgery, correlating with improved metabolic outcomes. These connections are supported by human clinical and mechanistic studies.

Black pepper's active alkaloid piperine has been studied in human clinical trials for effects on metabolic parameters including lipid profiles, glycemic indices, and inflammatory markers. A 2023 PMC systematic review found clinical evidence that piperine reduces total cholesterol, LDL-C, and triglycerides in overweight and obese individuals. Mechanistically, piperine activates the AMPK signaling pathway in skeletal muscle, upregulates UCP1, and modulates PPARγ activity—all pathways central to energy and lipid metabolism. Evidence quality is moderate: most positive human trials use piperine in combination (particularly with curcumin), making piperine's independent contribution harder to isolate.

Black tea influences multiple metabolic parameters including lipid metabolism, glucose metabolism, and energy expenditure via caffeine-mediated thermogenesis. Clinical evidence for lipid and glucose effects is mixed; the caffeine-driven thermogenic effect has more consistent support. Gut microbiota modulation by black tea polyphenols also affects systemic metabolic signaling.

Bladderwrack provides iodine essential for thyroid hormone (T3/T4) synthesis, which governs basal metabolic rate. Iodine-deficiency-related hypothyroidism causes metabolic slowdown; adequate iodine corrects this. This is the best-established mechanism, supported by broad physiological and some clinical evidence.

Brown rice protein contributes to metabolic health through its thermic effect (protein requires more energy to digest than carbohydrates or fats), its amino acid content supporting enzyme synthesis, and the metabolic syndrome-modifying effects documented in a 2025 8-week RCT in 50 participants. Meta-analyses further link brown rice to reductions in weight, BMI, and waist circumference — key metabolic parameters.

Caffeine has well-documented, clinically measured effects on human metabolism, primarily by increasing resting metabolic rate (RMR) and stimulating thermogenesis. Multiple human RCTs and controlled studies show acute caffeine ingestion raises RMR by approximately 3–12% for several hours, depending on dose and population. It also promotes lipolysis and fat oxidation, though the magnitude of these effects is attenuated in obese individuals and habitual caffeine users.

Capsaicin has robust human clinical evidence supporting its role in boosting metabolism. It acts primarily via TRPV1 receptor activation, stimulating thermogenesis, increasing resting metabolic rate, and enhancing fat oxidation. A 2020 meta-analysis of 13 placebo-controlled trials found capsaicinoids significantly raised resting metabolic rate by ~34 kcal/day; however, the overall magnitude of these effects is modest.

Capsaicinoids reliably increase resting energy expenditure by approximately 50 kcal/day in controlled human trials and enhance lipid oxidation by around 20%. They activate brown adipose tissue thermogenesis via TRPV1 and promote fat oxidation. These are among the most robustly documented metabolic effects of any dietary compound.

Capsanthin activates key metabolic regulators AMPK and adiponectin, promotes fatty acid oxidation via adrenoceptor-β2 agonism, and modulates lipid and glucose metabolism in preclinical models. Its anti-adipogenic and lipolytic effects point to broad metabolic activity.

Capsaicin is one of the most clinically studied dietary compounds for metabolic rate enhancement, with multiple human trials and meta-analyses confirming increased resting energy expenditure, fat oxidation, and sympathetic nervous system activation following acute and chronic capsaicin ingestion.

Human clinical trial evidence shows caraway extract significantly reduces body weight, BMI, and body fat percentage without dietary restriction, suggesting metabolic effects on fat utilization. Proposed mechanisms include modulation of gut microbiota, inhibition of adipogenesis, and anti-inflammatory modulation of lipid metabolism genes.

Catechins—particularly EGCG—increase resting energy expenditure, enhance fat oxidation, and improve metabolic biomarkers including triglycerides, blood glucose, and adiponectin. They modulate key metabolic enzymes and signaling pathways including AMPK and lipid synthesis gene expression.

Capsaicin consistently increases resting energy expenditure and fat oxidation in human studies by activating brown adipose tissue (BAT) through TRPV1 signalling. Studies typically report a 4–5% increase in metabolic rate, enhanced lipolysis, and reduced fat accumulation with sustained capsaicin intake.

Chen Pi's PMFs activate AMPK in adipose tissue and liver, modulating lipid and glucose metabolism. Clinical evidence shows improvements in cholesterol, triglycerides, fasting blood glucose, and insulin sensitivity. PMFs also regulate gut microbiota metabolites influencing systemic metabolic function.

Chlorogenic acid (CGA) has meaningful human clinical evidence supporting its role in modulating key aspects of metabolism, including glucose homeostasis, insulin sensitivity, lipid profiles, and body weight. Multiple RCTs demonstrate reductions in fasting blood glucose, HbA1c, HOMA-IR, and BMI with CGA supplementation. Its primary metabolic mechanisms — inhibiting hepatic glucose-6-phosphatase, suppressing α-glucosidase, and activating AMPK — have been confirmed in both preclinical and translational human research. Evidence is strongest for glucose and lipid metabolism in the context of metabolic syndrome and type 2 diabetes risk.

Choline is an essential nutrient with well-documented, clinically supported roles in metabolism, particularly lipid and hepatic metabolism. It is required for the synthesis of phosphatidylcholine, which enables hepatic VLDL secretion and fat export from the liver; deficiency causes hepatic steatosis (fatty liver) in humans. Choline also participates in one-carbon/methyl metabolism via its conversion to betaine, and regulates homocysteine metabolism. Inadequate choline intake is linked to metabolic disorders including NAFLD and metabolic syndrome.

Chromium (as trivalent Cr III) plays a documented role in glucose and insulin metabolism, with human clinical trials and multiple systematic reviews showing meaningful glycemic improvements specifically in people with type 2 diabetes. The proposed mechanism involves enhancement of insulin receptor signaling via a low-molecular-weight chromium-binding substance. Evidence in non-diabetic or pre-diabetic populations is weak and inconsistent, and the overall body of literature is limited by heterogeneity and study-quality concerns.

Multiple systematic reviews and meta-analyses of randomized controlled trials (RCTs) demonstrate that cinnamon supplementation produces statistically significant improvements in fasting blood glucose, HbA1c, and lipid profiles, particularly in individuals with type 2 diabetes and metabolic syndrome. The evidence is mechanistically grounded in cinnamon's bioactive compounds—cinnamaldehyde, trans-cinnamic acid, and type-A procyanidins—which modulate insulin signaling, AMPK activation, and PPAR pathways. Results across trials remain heterogeneous, and effect sizes are modest, meaning cinnamon is best characterized as an adjunctive metabolic support rather than a standalone therapy.

CLA has been studied in multiple human clinical trials and systematic reviews for its effects on metabolism, primarily through modulation of fat oxidation, lipolysis, and body composition. The two main isomers (cis-9, trans-11 and trans-10, cis-12) act via PPAR receptor pathways to influence lipid metabolism and energy expenditure. Human evidence shows modest but statistically significant effects on body weight, BMI, and fat mass, though results are inconsistent across studies and far less pronounced than in animal models. Some evidence also points to adverse metabolic effects, including reductions in HDL cholesterol and, in certain populations, worsened insulin sensitivity.

MCTs in coconut oil are metabolized via the portal vein directly to the liver, bypassing lymphatic absorption, and are preferentially oxidized for energy rather than stored as fat. Animal studies show coconut oil diet suppressed weight gain and improved glucose tolerance versus lard. Human RCT data show no significant metabolic advantages over other cooking oils at typical doses.

The MCTs in coconut milk are absorbed and metabolized faster than long-chain fats, transported directly to the liver and rapidly oxidized for energy or converted to ketones. This unique pathway increases diet-induced thermogenesis by approximately 16% compared to long-chain triglycerides, making coconut milk metabolically distinct from most dietary fats.

MCTs in coconut oil are transported directly to the liver and rapidly oxidized, producing a faster metabolic response than long-chain triglycerides. Human trials show MCTs increase energy expenditure and fat oxidation modestly, but clinical coconut oil trials have not demonstrated significant improvements in glycemic or metabolic markers vs. nontropical vegetable oils.

Coffee polyphenols, especially those found in coffee fruit, enhance energy metabolism and reduce lipogenesis. Chlorogenic acid has been shown to activate fat metabolism in the liver, reduce hepatic triglycerides, and modulate adipogenesis in cell and animal models. Human trials with CGA-rich extracts show effects on body fat, lipid metabolism, and glucose regulation consistent with metabolic enhancement.

Coleus forskohlii's bioactive compound forskolin activates adenylate cyclase, raising intracellular cAMP levels that stimulate lipolysis, thermogenesis, and energy expenditure—directly influencing metabolic function. Multiple small human RCTs have examined its effects on body composition and metabolic parameters, with the most notable finding improvements in fat mass, insulin sensitivity, and lipid markers. Evidence is promising but limited by small sample sizes and the need for larger confirmatory trials.

CoQ10 is a biochemically essential component of the mitochondrial electron transport chain, directly enabling cellular ATP synthesis via oxidative phosphorylation — making it a foundational element of metabolic energy production. Beyond this core bioenergetic role, CoQ10 participates in fatty acid β-oxidation, pyrimidine biosynthesis, and gene expression related to cellular metabolism. Clinical trials and meta-analyses document measurable improvements in glycemic markers (fasting glucose, HbA1c, HOMA-IR) in individuals with type 2 diabetes or metabolic syndrome, particularly at doses of 100–200 mg/day. Evidence for broader metabolic benefits (e.g., lipid profiles, oxidative stress reduction) is supported by multiple RCTs, though effect sizes are generally modest.

Cumin has demonstrated effects on several metabolic parameters in RCTs including body weight, BMI, fat mass, lipid profiles, and blood sugar. Animal studies confirm cumin stimulates digestive enzyme and bile production, accelerating nutrient metabolism. RCT meta-analyses confirm broad metabolic activity.

Dulse's iodine content supports thyroid hormone synthesis, which is the primary hormonal regulator of basal metabolic rate. Dulse protein hydrolysates have also demonstrated DPP-4 inhibition and incretin (GLP-1, GIP) stimulation in vitro, both of which regulate metabolic hormone signaling. These mechanisms are documented at the biochemical/preclinical level.

EGCG, the predominant catechin in green tea, has human clinical evidence supporting its role in modulating metabolism, primarily through effects on energy expenditure, lipid metabolism, and fat oxidation. Multiple randomized controlled trials and systematic reviews confirm modest but measurable metabolic effects. Mechanistically, EGCG activates AMP-activated protein kinase (AMPK) and inhibits catechol-O-methyltransferase (COMT), both of which shift substrate utilization toward fat oxidation and reduce lipogenesis. Evidence is strongest for improvements in lipid profiles and body composition, though effect sizes are generally modest.

Fenugreek has substantial clinical evidence supporting its role in metabolic health, particularly glycemic and lipid regulation. Multiple RCTs and meta-analyses demonstrate significant reductions in fasting blood glucose, HbA1c, triglycerides, and improved insulin sensitivity in individuals with type 2 diabetes or metabolic syndrome. Its primary bioactive constituents—the soluble fiber galactomannan and the amino acid 4-hydroxyisoleucine—are the most studied mechanistic drivers. Evidence is strongest in diabetic populations; effects in healthy individuals are less consistent.

FMN and FAD are required cofactors for dozens of flavoenzymes involved in the metabolism of carbohydrates, fats, and proteins, including enzymes in the citric acid cycle, fatty acid beta-oxidation, and amino acid catabolism. Riboflavin deficiency, which depletes cellular FMN and FAD, leads to impaired fatty acid oxidation and mitochondrial dysfunction. Repletion studies confirm restoration of these metabolic functions.

Forskolin increases cAMP-driven lipolysis via hormone-sensitive lipase activation, promotes thermogenesis, and may mildly stimulate thyroid hormone secretion. Multiple human RCTs show reductions in body fat percentage and fat mass, with one 12-week DBPC trial in men showing significant decreases versus placebo by DXA.

Fucoxanthin, a marine carotenoid from brown seaweeds, has documented metabolic effects supported by both preclinical and human clinical evidence. Its primary mechanism involves induction of uncoupling protein-1 (UCP1) in white adipose tissue, increasing energy expenditure and fatty acid oxidation. Human trials, while limited in number, show significant improvements in resting energy expenditure, body weight, body fat, and blood glucose markers.

Garcinia cambogia, via its active compound hydroxycitric acid (HCA), has a well-characterized proposed mechanism for influencing lipid metabolism: inhibition of ATP-citrate lyase, the enzyme that generates acetyl-CoA for fatty acid synthesis. Multiple RCTs and meta-analyses in humans have been conducted, showing statistically significant but clinically modest effects on body weight, BMI, and fat mass. Overall evidence is mixed and effect sizes are small, with some rigorous trials finding no meaningful difference versus placebo.

Multiple human RCTs and meta-analyses show ginger (Zingiber officinale) modestly improves several metabolic parameters, including glycemic control, lipid profiles, thermogenesis, and body composition. Its bioactive compounds—primarily gingerols and shogaols—appear to act via enzyme inhibition in carbohydrate metabolism, enhanced diet-induced thermogenesis, and improved insulin sensitivity. Evidence is encouraging but limited by small trial sizes and methodological heterogeneity.

Glucomannan, a highly viscous soluble fiber from Amorphophallus konjac, has robust clinical evidence supporting its role in metabolic regulation. Multiple RCTs and meta-analyses demonstrate significant reductions in fasting blood glucose, LDL cholesterol, total cholesterol, and triglycerides, alongside modest weight loss. Its primary mechanism involves gel formation in the GI tract, slowing gastric emptying and blunting postprandial glucose and insulin responses. Evidence is strongest in adults with dyslipidemia, overweight/obesity, or type 2 diabetes.

Green tea has robust clinical and mechanistic evidence supporting its role in boosting metabolism. Its primary active compound, epigallocatechin-3-gallate (EGCG), inhibits the enzyme COMT, prolonging the activity of norepinephrine and thereby stimulating thermogenesis and fat oxidation. Multiple human RCTs and meta-analyses confirm modest but significant increases in energy expenditure and reductions in body weight and fat mass. Effect sizes are generally small, and results vary by population, genetics, and whether caffeine is co-administered.

Guarana's caffeine content increases metabolic rate via thermogenesis and AMPK activation, effects well established for methylxanthines. Epidemiological data link habitual guarana consumption to lower obesity prevalence and better metabolic biomarkers in elderly Amazonian people. Animal studies confirm anti-adipogenic and metabolic-correcting effects across obesity models.

Guggul (Commiphora wightii/mukul) contains active steroidal ketones called guggulsterones (E- and Z-isomers) that influence lipid and energy metabolism through multiple mechanisms, including antagonism of the farnesoid X receptor (FXR) and stimulation of thyroid function. Clinical evidence for lipid-lowering effects is mixed: older Indian trials suggested benefit, while a 2003 randomized controlled trial published in JAMA found no improvement in LDL and a potential LDL increase in some participants. Animal and in vitro evidence for thyroid-mediated metabolic stimulation exists, but robust human trials in this area are lacking.

Gymnema sylvestre has meaningful clinical evidence supporting its role in metabolic health, primarily through improving glycemic control and lipid parameters. Its key bioactives—gymnemic acids—inhibit intestinal glucose absorption, stimulate pancreatic insulin secretion, and suppress carbohydrate-digesting enzymes. Multiple human RCTs and a meta-analysis confirm reductions in fasting blood glucose and HbA1c, with more modest lipid effects. Evidence base is real but limited by small sample sizes and heterogeneity across trials.

Hydroxycitric acid (HCA), the primary active compound in Garcinia cambogia, exerts metabolic effects chiefly by competitively inhibiting ATP-citrate lyase, a key enzyme in the de novo synthesis of fatty acids from carbohydrates. Human clinical trials and a published meta-analysis confirm a small but statistically significant effect on body weight and lipid profiles. However, results across RCTs are inconsistent, and overall effect sizes are modest, with regulators such as NCCIH characterizing the weight-loss evidence as unclear.

Inositol — primarily its myo-inositol (myo-Ins) and D-chiro-inositol (DCI) isoforms — functions as a second messenger in insulin receptor signalling, directly influencing glucose uptake and lipid metabolism. Multiple systematic reviews and meta-analyses of RCTs demonstrate statistically significant reductions in fasting glucose, insulin, HOMA-IR, triglycerides, and LDL-cholesterol in populations with obesity, PCOS, T2DM, NAFLD, and gestational diabetes. Evidence is strongest for glycaemic outcomes (moderate certainty for insulin/HOMA-IR) and more limited for anthropometric endpoints (low/very-low certainty per GRADE).

Iodine is an essential micronutrient whose primary and well-established biological role is as an obligate substrate for the synthesis of thyroid hormones T3 and T4. These hormones directly regulate basal metabolic rate, protein synthesis, and enzymatic activity across virtually all tissues. Iodine deficiency impairs thyroid hormone production, leading to hypothyroidism and its associated metabolic slowing, while adequate iodine intake is foundational to normal metabolic homeostasis.

Isoleucine is a central regulator of whole-body metabolism, influencing glucose homeostasis, fatty acid oxidation, and energy substrate utilization. Its catabolism connects directly to TCA cycle activity, and dietary isoleucine levels modulate hepatic insulin sensitivity, ketogenesis, and energy expenditure via the FGF21-UCP1 axis. Dysregulation of isoleucine metabolism is implicated in insulin resistance and type 2 diabetes.

Jiaogulan activates AMPK—the master metabolic regulator—promoting fat oxidation, improving insulin sensitivity, reducing hepatic lipogenesis, and enhancing mitochondrial biogenesis. These metabolic effects are supported by both in vitro, animal, and human clinical data.

Kelp's primary metabolic relevance is through its rich iodine content, which is essential for thyroid hormone (T3/T4) synthesis and thereby governs basal metabolic rate. A double-blind RCT of 36 euthyroid subjects found kelp supplementation dose-dependently raised TSH, confirming thyroid axis engagement. Basal metabolic rate, however, did not change significantly over 4 weeks in that trial.

L-Alanine is a central metabolic hub linking muscle catabolism, hepatic gluconeogenesis, nitrogen disposal, and the urea cycle. It is the most important single amino acid for inter-organ carbon and nitrogen trafficking. Hepatic AMPK activation by L-alanine has also been demonstrated, linking it to broader metabolic regulation.

L-carnitine plays a well-established biochemical role in metabolism by shuttling long-chain fatty acyl-CoA groups across the inner mitochondrial membrane, enabling beta-oxidation and ATP production. Multiple meta-analyses of RCTs demonstrate that supplementation significantly improves glycemic markers (fasting blood glucose, insulin, HOMA-IR, HbA1c) and lipid profiles. Evidence is strongest in populations with impaired glucose tolerance, type 2 diabetes, or dyslipidemias, with more modest effects in healthy individuals.

Isoleucine has unique metabolic effects distinguishable from other BCAAs, including promotion of glucose oxidation, inhibition of hepatic gluconeogenesis, and regulation of body composition. Human epidemiological data show dietary isoleucine levels correlate significantly with BMI, independent of total protein intake. Animal and mechanistic research confirms isoleucine regulates energy expenditure and metabolic homeostasis.

Leucine is a central regulator of cellular metabolic sensing through its role as the primary activator of mTORC1, coordinating protein synthesis, lipid metabolism, glucose homeostasis, and adiponectin secretion. It increases protein synthesis in muscle, adipose tissue, and liver via multiple mechanisms and modulates AMPK signaling, making it a nutrient-metabolic signal of unusually broad reach.

L-Valine is a central metabolic substrate: it is catabolized in skeletal muscle through the BCAT enzyme, contributes to gluconeogenesis, feeds the citric acid cycle as succinyl-CoA, and participates in interorgan nitrogen shuttling. Elevated circulating valine is robustly associated with insulin resistance and type 2 diabetes risk in human epidemiological studies. Its catabolite 3-hydroxyisobutyrate (3-HIB) has been shown to modulate lipid uptake in human muscle.

Luteolin, a dietary flavone, has demonstrated significant metabolic effects in preclinical studies, including improving insulin sensitivity, reducing hyperglycemia, and alleviating hepatic steatosis through multiple signaling pathways such as AMPK, PI3K/Akt, and PPARγ. A 2025 critical review identified around 19 animal studies and 3 human studies documenting its modulation of glycolipid metabolism. Evidence in humans remains limited, and poor bioavailability is a recognized challenge. Overall, the scientific basis is real but predominantly preclinical, with clinical translation still in early stages.

Magnesium is a well-established cofactor in over 300–600 enzymatic reactions central to energy metabolism, including glycolysis, the Krebs cycle, and ATP synthesis. Clinical and epidemiological evidence links adequate magnesium status to improved insulin sensitivity, glucose regulation, and reduced risk of metabolic syndrome. Meta-analyses of prospective cohort studies show high magnesium intake is associated with a 21–39% lower odds of metabolic syndrome compared to low intake. Some RCT evidence supports improvements in insulin resistance markers, though individual trial results remain mixed.

Manganese serves as a cofactor for arginase, pyruvate carboxylase, glutamine synthetase, and MnSOD—enzymes that are central to carbohydrate, amino acid, cholesterol, and energy metabolism. These are well-established biochemical roles confirmed by the NIH ODS and multiple peer-reviewed sources.

Medium chain triglycerides (MCTs) have well-documented metabolic effects supported by multiple human clinical trials and systematic reviews. Unlike long-chain triglycerides (LCTs), MCTs are rapidly absorbed via the portal vein and undergo obligate hepatic oxidation, bypassing carnitine-dependent mitochondrial transport. This unique pathway drives increased thermogenesis, enhanced fat oxidation, and elevated energy expenditure compared to LCTs. A 2024 meta-analysis confirmed MCT-enriched diets produce significantly greater weight reduction and improvements in glucolipid metabolism in overweight individuals.

Morus alba extracts modulate key metabolic parameters including glucose metabolism, lipid metabolism, and energy homeostasis. Multiple human RCTs demonstrate improvements in glucose, insulin, cholesterol, and triglycerides. The 2025 meta-analysis confirmed mulberry's broad metabolic effects across 15 RCTs in 1,202 participants.

Mulberry leaf extract activates AMPK, a master metabolic regulator, in skeletal muscle and liver, improving glucose and lipid metabolism. Multiple clinical trials confirm improved glucose tolerance, insulin levels, and lipid profiles. These effects collectively represent a meaningful impact on systemic metabolic function.

N-Acetyl Cysteine (NAC) supports metabolic health primarily as a glutathione precursor that reduces oxidative stress, a key driver of insulin resistance and metabolic dysfunction. Clinical trials in metabolic syndrome patients show NAC (1800 mg/day for 12 weeks) significantly reduced fasting glucose, fasting insulin, and insulin resistance indices while raising HDL-cholesterol. Evidence also exists for benefit in NAFLD-related metabolic complications, though larger trials are still needed to confirm many findings.

Naringin and naringenin increase metabolic rate, improve lipid and glucose metabolism, and activate PPAR pathways in human adipocytes. In a clinical case study, naringenin raised resting metabolic rate by 3.5% over 8 weeks. Preclinical data across obese models consistently show improvements in multiple metabolic parameters including lipid profiles, glycemic indices, and adiposity.

Nicotinamide riboside (NR) is an orally bioavailable NAD+ precursor vitamin that reliably raises blood and tissue NAD+ levels in humans in a dose-dependent manner. NAD+ is a central coenzyme in redox reactions underpinning glycolysis, oxidative phosphorylation, and fatty acid oxidation. While preclinical studies show robust metabolic benefits (improved insulin sensitivity, mitochondrial biogenesis, protection against diet-induced obesity), most short-term human RCTs have not replicated these outcomes for insulin sensitivity, resting energy expenditure, or body composition. Longer-term supplementation (5 months) has shown improvements in muscle mitochondrial number and gut microbiota, but overall human evidence for broad metabolic benefit remains limited and mixed.

NMN is a direct biosynthetic precursor to NAD+, a coenzyme central to cellular energy metabolism, glycolysis, the TCA cycle, and mitochondrial oxidative phosphorylation. Human clinical trials confirm that oral NMN reliably raises blood NAD+ levels. However, a 2024 meta-analysis of eight RCTs found no statistically significant improvements in standard metabolic markers—fasting glucose, insulin, HbA1c, HOMA-IR, or lipid profile—in predominantly non-diabetic adults. One notable RCT reported improved muscle insulin sensitivity in prediabetic women, suggesting benefits may be context- or population-dependent. Overall, the mechanistic rationale is well-established, but clinical evidence for meaningful metabolic benefit in humans remains limited and inconsistent.

Omega-3 fatty acids (EPA and DHA) have well-documented metabolic effects, most robustly demonstrated in reducing plasma triglycerides—a central component of metabolic syndrome. They also influence lipid oxidation, hepatic VLDL production, and inflammatory pathways linked to insulin resistance. Evidence for improving insulin sensitivity directly in humans is inconsistent, though effects on dyslipidemia and blood pressure in metabolic syndrome are supported by multiple RCTs and meta-analyses.

Bile acids are now recognized as hormonal signaling molecules that regulate triglyceride, cholesterol, glucose, and energy homeostasis via FXR and TGR5 receptors. Research published in peer-reviewed journals has confirmed that bile acid pathways intersect with metabolic syndrome phenotypes. However, these metabolic effects are primarily studied with prescription bile acid analogues and sequestrants; direct metabolic evidence for OTC ox bile supplementation in humans is mechanistic rather than from RCTs.

POA is a lipokine that coordinates metabolic crosstalk between adipose tissue, liver, and skeletal muscle. It activates PPARα and PPARγ receptors, reduces ectopic lipid deposition, and improves multiple metabolic parameters including glucose metabolism, lipid profiles, and inflammatory cytokine gene expression.

Piperine, the principal alkaloid of black pepper (Piper nigrum), has documented effects on metabolic function via multiple mechanisms: inhibition of cytochrome P450 enzymes and phase II metabolism (increasing bioavailability of co-administered nutrients and drugs), activation of AMPK and thermogenic pathways in muscle and adipose tissue, and improvement of glucose and lipid metabolism. Human clinical evidence includes a randomized double-blind trial showing that 5 mg/day piperine for 12 weeks significantly reduced hepatic enzymes, blood glucose, dyslipidemia, and insulin resistance (HOMA) in NAFLD patients. However, direct thermogenic effects at dietary doses have not been confirmed in controlled human studies.

Quercetin, a polyphenolic flavonoid found widely in fruits and vegetables, has documented effects on multiple components of metabolism, including glucose regulation, lipid homeostasis, and insulin sensitivity. Clinical meta-analyses of randomized controlled trials show significant, if modest, reductions in fasting blood glucose, LDL-cholesterol, total cholesterol, and systolic blood pressure. The primary mechanistic driver appears to be activation of the AMPK signaling pathway, which simultaneously suppresses fatty acid synthesis and promotes fatty acid oxidation. Human clinical evidence exists but remains limited in scale and follow-up duration, so findings should be interpreted cautiously.

Quinoa positively influences multiple metabolic parameters in clinical trials: lowering blood glucose, triglycerides, LDL-cholesterol, and improving insulin resistance index. Its mineral content (magnesium, manganese) directly supports over 300 enzymatic metabolic reactions. Manganese is specifically essential for carbohydrate and fat metabolism. A 2025 comprehensive review confirmed quinoa's role in improving metabolic parameters.

Resveratrol, a polyphenol found in red grapes and red wine, has been studied extensively for its effects on metabolic health. Human clinical trials and meta-analyses demonstrate modest but consistent improvements in glucose levels, insulin sensitivity, triglycerides, waist circumference, and HDL cholesterol in individuals with metabolic syndrome. However, results across trials are mixed, and no consensus dosing regimen has been established for any metabolic indication.

Caffeine from robusta coffee increases resting metabolic rate and promotes lipolysis through sympathomimetic mechanisms including catecholamine elevation and phosphodiesterase inhibition. Chlorogenic acids modulate carbohydrate and lipid metabolism via G6Pase inhibition and AMPK activation. A 2023 review confirmed that coffee and caffeine consumption improves multiple metabolic variables including thermogenesis, lipolysis, and insulin sensitivity.

Z. bungeanum bioactives—including HAS, hyperoside, quercetin, and rutin—modulate multiple metabolic parameters (blood glucose, lipid profiles, adipogenesis, AMPK signalling) in preclinical models. The herb is described in TCM as having antiobesity and antidiabetic effects. No human metabolic RCT data.

Spirulina has demonstrated effects across multiple metabolic parameters in human trials, including reductions in body weight, fasting glucose, triglycerides, and total cholesterol, alongside improvements in insulin sensitivity and antioxidant status. A systematic review identified 13 human clinical studies documenting broad metabolic improvements across dosages from 20 mg to 6 g over 17–360 days. The active compounds phycocyanin, gamma-linolenic acid, and glycolipid H-b2 are identified as key mediators.

In rodent models, succinic acid supplementation enhances fat metabolism by promoting white adipose tissue browning, reducing adiposity, and improving lipid profiles. One mouse study (PMC, 2024) found decreased serum TG, TC, and LDL-C alongside increased HDL-C. Mechanisms involve PGC-1α/UCP1 signaling via P38/MAPK and increased mitochondrial biogenesis.

p-Synephrine, the primary protoalkaloid of bitter orange (Citrus aurantium), has human clinical evidence supporting modest increases in resting metabolic rate (RMR) and fat oxidation. Its proposed mechanism involves partial agonism at β-3 adrenergic receptors, which are linked to thermogenesis and lipolysis. However, a 2022 systematic review and meta-analysis found no significant weight loss effect from prolonged use, and evidence for sustained metabolic benefit remains limited.

Taurine has clinically documented effects on key metabolic parameters, supported by human RCTs and meta-analyses. A 2024 systematic review and meta-analysis of 25 RCTs (1,024 participants) found significant reductions in fasting blood glucose, triglycerides, and blood pressure with taurine supplementation. Mechanistically, taurine improves insulin sensitivity, modulates bile acid conjugation, supports mitochondrial function, and reduces oxidative stress and inflammation. Current clinical evidence is promising but limited by small sample sizes and short study durations.

Tongkat Ali's elevation of testosterone and reduction of cortisol produce downstream metabolic benefits including improved lean-to-fat mass ratios. Clinical data show increased lean body mass and fat loss in exercise-combined trials. The 2018 RCT using TA with multivitamins noted decreased glucose concentrations in stressed subjects. Preclinical evidence documents antihyperglycemic and steroidogenic activity, supporting metabolic influence. Evidence in humans is indirect, derived from hormonal and body composition endpoints.

Vitamin B1 (thiamine) is a scientifically established, essential cofactor in energy metabolism. Its active form, thiamine diphosphate (TDP/TPP), is required by key enzymes—pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase—that govern carbohydrate, amino acid, and fatty acid catabolism. The NIH Office of Dietary Supplements confirms it 'plays a critical role in energy metabolism and, therefore, in the growth, development, and function of cells.' Thiamine deficiency directly impairs these pathways, causing pyruvate and lactate accumulation, reduced ATP production, and multisystem metabolic dysfunction.

Vitamin B2 (riboflavin) is an essential micronutrient whose role in metabolism is scientifically established and mechanistically well-characterized. It serves as the precursor to two critical coenzymes—flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD)—that drive oxidation-reduction reactions central to energy production from carbohydrates, fats, and amino acids. These coenzymes are indispensable components of the mitochondrial electron transport chain and the citric acid cycle. Riboflavin deficiency directly impairs these metabolic pathways, causing fatigue, normocytic anemia, and secondary deficiencies in other B vitamins, confirming its non-redundant metabolic role.

Vitamin B3 (niacin) is a foundational component of cellular metabolism, serving as the biosynthetic precursor to NAD+ and NADP+—coenzymes that drive oxidation-reduction reactions across glycolysis, the TCA cycle, fatty acid oxidation, and amino acid metabolism. At pharmacological doses, nicotinic acid also directly modulates lipid metabolism by inhibiting hepatic triglyceride synthesis and altering HDL/LDL profiles. The evidence base is robust, spanning biochemical characterization, human clinical trials, and systematic reviews involving thousands of participants.

Vitamin B5 (pantothenic acid) is an indispensable component of coenzyme A (CoA), a cofactor involved in hundreds of biochemical reactions central to energy metabolism, including the catabolism of carbohydrates, fats, and proteins via the citric acid cycle and fatty acid oxidation. This role is mechanistically established and reflected in official Dietary Reference Intakes. Deficiency—though rare in normal diets—produces metabolic impairments including hypoglycemia and increased insulin sensitivity, confirming its functional necessity. No Tolerable Upper Intake Level has been set due to low toxicity, and the adult Adequate Intake (AI) is 5 mg/day.

Vitamin B6, primarily in its active coenzyme form pyridoxal 5'-phosphate (PLP), is a well-established participant in over 100–160 enzymatic reactions central to macronutrient metabolism. It is essential for amino acid, carbohydrate, and lipid metabolism, including transamination, gluconeogenesis, glycogenolysis, and sphingolipid processing. Deficiency measurably disrupts these pathways, as confirmed by metabolomic studies in humans. The RDA for adults (1.3 mg/day) is set with plasma PLP ≥20 nmol/L as the adequacy criterion.

Vitamin B7 (Biotin) is an essential cofactor for five carboxylase enzymes that are directly responsible for the metabolism of carbohydrates, fats, and amino acids. Without adequate biotin, these enzymes cannot function, making it indispensable for gluconeogenesis, fatty acid synthesis and oxidation, and amino acid catabolism. Clinical evidence from biotinidase-deficiency studies confirms that loss of biotin-dependent enzyme activity produces measurable metabolic disruption including organic aciduria and ketolactic acidosis. The Adequate Intake for adults is 30 µg/day, and true deficiency is rare in healthy adults on a balanced diet.

Whey protein favorably modulates multiple aspects of metabolism, including body composition (lean mass gain, fat mass reduction), glucose and lipid metabolism, and thermogenesis via its high thermic effect relative to carbohydrates and fats. RCTs and meta-analyses consistently show whey supports fat-free mass gains in exercise-trained individuals, and improves multiple cardiometabolic markers including triglycerides, blood pressure, and glycemic control.

Brewer's yeast modulates multiple metabolic parameters in clinical trials: improving glycemic indices, insulin sensitivity, lipid profiles, and blood pressure in type 2 diabetic patients. B-vitamins in yeast are essential enzymatic cofactors for carbohydrate, fat, and protein metabolism. GTF-chromium is the key active component for metabolic effects.

Yerba mate enhances energy expenditure, increases fat oxidation at rest and during exercise, and modulates mitochondrial efficiency in adipose and muscle tissue. Human and animal evidence supports thermogenic and metabolic rate-boosting effects through xanthine and polyphenol activity.

Yohimbine has documented effects on metabolic processes, primarily through increasing norepinephrine and stimulating lipolysis via α2-adrenergic receptor blockade. It raises circulating free fatty acids, potentiates postprandial insulin secretion, and has been shown to increase plasma norepinephrine but not adrenaline under chronic dosing in healthy volunteers. These are pharmacologically verified metabolic actions, though clinical endpoints such as sustained metabolic rate elevation remain less well-established.

Zinc is an essential trace element with well-documented roles in carbohydrate, lipid, and protein metabolism, functioning as a cofactor for over 300 metalloenzymes. It is critically involved in insulin synthesis, storage, and release, making it central to glucose homeostasis. Multiple randomized controlled trials demonstrate that zinc supplementation can improve insulin resistance, fasting glucose, and inflammatory markers in populations with metabolic dysfunction.

Pituitary substance has been traditionally associated with metabolic support through the gland's production of TSH (governing thyroid-mediated metabolic rate) and GH (influencing body composition and substrate metabolism). Traditional naturopathic practitioners listed sluggish metabolism among indications for pituitary support. No clinical trials exist for the oral supplement form.